Home › Compare › XALL vs JNJ

XALL vs JNJ: Dividend Comparison 2026

XALL yields 666666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XALL wins by $8.275235618773884e+34M in total portfolio value
10 years
XALL
XALL
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full XALL calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — XALL vs JNJ

📍 XALL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXALLJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XALL + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
XALL pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XALL
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, XALL beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XALL + JNJ for your $10,000?

XALL: 50%JNJ: 50%
100% JNJ50/50100% XALL
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

XALL
No analyst data
Altman Z
5.2
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XALL buys
0
JNJ buys
0
No recent congressional trades found for XALL or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXALLJNJ
Forward yield666666.67% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$8.275235618773884e+34M$20.0K ✓
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$8.275075881065991e+34M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: XALL vs JNJ ($10,000, DRIP)

YearXALL PortfolioXALL Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$66,677,367$66,666,666.67$10,676$355.77+$66.67M → XALL
2$415,506,651,117$415,435,306,334.37$11,407$389.39+$415506.64M → XALL
3$2,419,908,598,386,268$2,419,464,006,269,573.00$12,198$426.53+$2419908598.37M → XALL
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$13,056$467.62+$13171697643084.44M → XALL
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$13,987$513.12+$67004927492790120.00M → XALL
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$14,998$563.56+$318562277003514871808.00M → XALL
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$16,098$619.52+$1.415484168853553e+24M → XALL
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$17,295$681.69+$5.878130573362507e+27M → XALL
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$18,599$750.82+$2.2813793009840744e+31M → XALL
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$20,022$827.78+$8.275235618773884e+34M → XALL

XALL vs JNJ: Complete Analysis 2026

XALL — Stock

Xalles Holdings Inc. provides payment consulting and system solutions to government and business organizations. It offers payment solutions consultancy services, as well as systems for the financial reconciliation and auditing of business and government payment transactions. The company is based in Washington, District of Columbia.

Full XALL Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this XALL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XALL vs SCHDXALL vs JEPIXALL vs OXALL vs KOXALL vs MAINXALL vs ABBVXALL vs MRKXALL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.